Xellia Pharmaceuticals

Hikma acquires some Xellia US assets for up to $185M

London-based Hikma agreed to buy parts of Xellia’s assets in the U.S., including the Danish drugmaker’s manufacturing facility in Cleveland.

Joseph Keenan Jun 20, 2024 8:57am

layoffs job losses cuts workforce reduction

Xellia to axe 80 positions at Ohio plant previously owned by BI

Dec 13, 2023 9:19am

Green traffic light

Xellia released the first commercial drugs from its Ohio plant

Aug 17, 2021 5:59pm

buildings

Indiana CDMO drops $60M into first manufacturing facility

Oct 20, 2020 9:00am

Xellia

Xellia starts sterile injectable production at once vilified U.S

Mar 26, 2020 11:29am

Xellia

Xellia to produce antibiotics for hospital-backed Civica Rx

May 16, 2019 10:47am